Executive Director, Strategy & Commercial Development, Neuroscience
Core
Commercial leader accountable for maximizing the value of BMS's neurodegeneration portfolio (Alzheimer's, Parkinson's, DLB) from Discovery through Phase 3, defining integrated strategy, and preparing markets for launch.
Role type
Executive Director, Strategy & Commercial Development
Builds
Neurodegeneration pipeline assets and market presence
Domain
Biopharma / Neurodegenerative Diseases
Deliverable
product features
Required skills
Commercial strategy, market development, brand planning, long-range forecasting, competitive analysis, stakeholder influence, budget management, cross-functional leadership
Preferred skills
MBA, US and Global experience, Alzheimer's or movement disorders expertise, AI resource utilization
Technologies
None stated
Responsibilities
Leads worldwide brand planning and long-range forecasting; Owns Neurodegeneration Market Development including biomarker and diagnosis strategy; Sets strategic direction for neurodegeneration; Translates clinical evidence into brand strategy; Partners with opinion leaders and advocacy groups; Partners with Value, Access, and Pricing team; Builds understanding of local market dynamics; Leads and influences across functions to guide optimized development; Develops long-range plans and guides products through stage gates.
Seniority
Executive, strategic leadership